FacebookTwitterGoogle PlusLinkedin

Menu

Open Studies

1. Study sponsored by Akebia. It evaluates the effect of Oral Hypoxemia Inducing Factor in patients with anemia of chronic kidney disease.This medication will be a pill, and meant to stimulate low blood oxygen levels which will stimulate the kidneys to generate a hormone to make more red blood cells.

Inclusion criteria: Patients with a chronic Kidney Disease and are not yet on dialysis with a HGB between 9.5 g/dl and 12.0 g/dl, may or may not requiring epogen, and have had no recent gastro-intestinal bleeding or history of thrombus (i.e. blood clot) or history of lupus or organ transplant.

To participate must be an active outpatient at Renal Medicine Associates.

2. Study sponsored by Pfizer. It evaluates the effect of a CCR4/5 inhibitor on reduction of proteinuria in patients with diabetic nephropathy.

Inclusion Criteria: Patients with Chronic Kidney diseases resulting from Type II Diabetes, have protein in the urine and have been actively treated for Hypertension and have had no or history of peripheral vascular disease or obstructive uropathy or history of lupus or organ transplant

To participate must be an active outpatient at Renal Medicine Associates.

3. Study sponsored by Abbvie. It evaluates the effect of an Endothelin receptor inhibitor on proteinuria reduction in patients with diabetic nephropathy.

Inclusion Criteria: Patients with Chronic Kidney diseases resulting from Type II Diabetes have protein in the urine and are actively being treated for Hypertension and diabetes. Patients must not have moderate or severe swelling. Patients with a history of heart failure and patients receiving dialysis or those that are being evaluated for kidney transplant may not qualify for the study.

To participate must be an active outpatient at Renal Medicine Associates.

Contact research team member to join any of the active studies:

Hema Shah
(hema.s@renalmed.com)
Clinical Research Coordinator
Renal Medicine Associates
3821 MastheadNE
Albuquerque
NM 87109
Phone: 505-998-7460 or 505-998-7400